Advanced search
Publication Cover
Expert Review of Quality of Life in Cancer Care Volume 1, 2016 - Issue 3
Journal homepage
77
Views
1
CrossRef citations to date
0
Altmetric
Review

Patient-reported outcomes in advanced breast cancer: inside the label and approval documents

Yanni HaoNovartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, USA
,
Meaghan KroheAdelphi Values, Boston, MA, USACorrespondence[email protected]
,
Iyar MazarAdelphi Values, Boston, MA, USA
,
Nina GalipeauAdelphi Values, Boston, MA, USA
,
Catherine FoleyAdelphi Values, Boston, MA, USA
,
Denise GlobeNovartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, USA
,
Diane M. Turner-BowkerAdelphi Values, Boston, MA, USA
&
Alan L. ShieldsAdelphi Values, Boston, MA, USA
 show all
Pages 197-205 | Received 17 Feb 2016, Accepted 29 Mar 2016, Published online: 18 Apr 2016

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29. doi:10.3322/caac.21254.
  • Cardoso F, Harbeck N, Fallowfield L, et al. Locally recurrent or metastatic breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23 Suppl 7:vii11–vii9. doi:10.1093/annonc/mds232.
  • American Cancer Society. Breast cancer facts & figures 2013-2014. Atlanta: American Cancer Society; 2013.
  • Cardoso F, Costa A, Norton L, et al. ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2). Breast. 2014;23(5):489–502. doi:10.1016/j.breast.2014.08.009.
  • Beslija S, Bonneterre J, Burstein HJ, et al. Third consensus on medical treatment of metastatic breast cancer. Ann Oncol. 2009;20(11):1771–1785. doi:10.1093/annonc/mdp261.
  • Irvin W Jr., Muss HB, Mayer DK. Symptom management in metastatic breast cancer. Oncologist. 2011;16(9):1203–1214. doi:10.1634/theoncologist.2011-0159.
  • Mayer M, Lang K, Hurvitz S, et al. Symptom burden and quality of life among women with HER2(+) metastatic breast cancer. Breast J. 2015;21(2):208–210. doi:10.1111/tbj.12374.
  • Reed E, Simmonds P, Haviland J, et al. Quality of life and experience of care in women with metastatic breast cancer: a cross-sectional survey. J Pain Symptom Manage. 2012;43(4):747–758. doi:10.1016/j.jpainsymman.2011.05.005.
  • Basch E. The missing voice of patients in drug-safety reporting. N Engl J Med. 2010;362(10):865–869. doi:10.1056/NEJMp0911494.
  • Food and Drug Administration. Guidance for industry on patient-reported outcome measures: use in medical product development to support labeling claims; Availability. Fed Regist. 2009;74(235):65132–65133.
  • European Medicines Agency. Reflection paper on the Regulatory Guidance for the Use of Health-related Quality of Life (HRQL) measures in the evaluation of medicinal products. 2005 [2005 July 27].
  • European Medicines Agency. Reflection paper on the use of patient reported outcome (PRO) measures in oncology studies (draft). London: European Medicines Agency; 2014.
  • Gotay CC, Kawamoto CT, Bottomley A, et al. The prognostic significance of patient-reported outcomes in cancer clinical trials. J Clin Oncol. 2008;26(8):1355–1363. JCO.2007.13.3439[pii]. doi:10.1200/JCO.2007.13.3439
  • Lipscomb J, Gotay CC, Snyder CF. Patient-reported outcomes in cancer: a review of recent research and policy initiatives. CA Cancer J Clin. 2007;57(5):278–300. 57/5/278 [pii]. doi:10.3322/CA.57.5.278.
  • Brim RL, Pearson SD. The use and reporting of patient-reported outcomes in phase III breast cancer trials. Clin Trials. 2013;10(2):243–249. doi:10.1177/1740774513475529.
  • Zagadailov E, Fine M, Shields A. Patient-reported outcomes are changing the landscape in oncology care: challenges and opportunities for payers. Am Health Drug Benefits. 2013;6(5):264–274.
  • Hao Y. Patient-reported outcomes in support of oncology product labeling claims: regulatory context and challenges. Expert Rev Pharmacoecon Outcomes Res. 2010;10(4):407–420. doi:10.1586/erp.10.45.
  • National Comprehensive Cancer Network. NCCN Clinical Practice Guidelins in Oncology: Breast Cancer, Version 1.2016. [Accessed 2015 Nov 23]. Available from: http://www.nccn.org/professionals/physician_gls/PDF/breast.pdf
  • Deal LS, DiBenedetti DB, Williams VS, et al. The development and validation of the daily electronic endometriosis pain and bleeding diary. Health Qual Life Outcomes. 2010;8:64. doi:10.1186/1477-7525-8-64.
  • Basch E, Geoghegan C, Coons S, et al. Patient-reported outcomes in cancer drug development and us regulatory review: perspectives from industry, the food and drug administration, and the patient. JAMA Oncol. 2015;1(3):375–379. doi:10.1001/jamaoncol.2015.0530
  • Rock EP, Scott JA, Kennedy DL, et al. Challenges to use of health-related quality of life for food and drug administration approval of anticancer products. JNCI Monographs. 2007(37):27–30. doi:10.1093/jncimonographs/lgm006.
  • Bylicki O, Gan HK, Joly F, et al. Poor patient-reported outcomes reporting according to CONSORT guidelines in randomized clinical trials evaluating systemic cancer therapy. Ann Oncol. 2015;26(1):231–237. doi:10.1093/annonc/mdu489.
  • Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA. 1996;276(8):637–639.
  • Calvert M, Blazeby J, Altman DG, et al. Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension. JAMA. 2013;309(8):814–822. doi:10.1001/jama.2013.879.
  • Efficace F, Fayers P, Pusic A, et al. Quality of patient-reported outcome reporting across cancer randomized controlled trials according to the CONSORT patient-reported outcome extension: A pooled analysis of 557 trials. Cancer. 2015;121(18):3335–3342. doi:10.1002/cncr.29489.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.